Depression Raises Risk for Type 2 Diabetes

Study Shows Treating Depression May Help Protect Against Type 2 Diabetes

Medically Reviewed by Louise Chang, MD on June 08, 2009
From the WebMD Archives

June 8, 2009 -- Treating depression improves insulin resistance in patients at risk for type 2 diabetes, a new study shows.

The research strongly suggests that depression is a direct risk factor for type 2 diabetes and that treating depression may protect against the disease.

The link between depression and diabetes has long been recognized, with some studies showing people with type 2 diabetes have twice the risk for depression as the general population.

But it has not been clear if lifestyle factors associated with both depression and type 2 diabetes -- such as being overweight, poor nutrition, and lack of exercise -- explain the association.

While these factors are important, the new research adds to the evidence that biological as well as lifestyle factors contribute to type 2 diabetes, researcher Julie Wagner, PhD, of the University of Connecticut Health Center, tells WebMD.

Wagner's study was presented Saturday at a meeting of the American Diabetes Association in New Orleans.

"Insulin resistance is the hallmark of type 2 diabetes, and this study shows that treating depression is associated with improved insulin resistance," Wagner tells WebMD.

Depression and Diabetes

The study included 55 people considered at risk for type 2 diabetes enrolled in a diabetes-prevention program. Most of the participants obese had prediabetes.

Using a widely accepted test for depression, one in three study participants was found to be clinically depressed and about one in five of these patients was taking antidepressant drugs.

Depressed participants who were not being treated had significantly greater insulin resistance than study participants who were not depressed. But treatment for depression appeared to improve insulin sensitivity, with depressed participants on antidepressant therapy having similar insulin sensitivity to non-depressed participants.

The difference remained even after the researchers controlled for physical activity, which is protective against both insulin resistance and depression.

"Basically the depressed people on medication looked like the non-depressed people in terms of insulin sensitivity," Wagner says.

Stress Hormones and Belly Fat

The findings support a recently published analysis of more than a dozen studies suggesting that depression is a much stronger risk factor for type 2 diabetes than diabetes is for depression.

There are several theories about how depression may contribute to type 2 diabetes, but the most widely cited theory involves the stress hormone cortisol.

Cortisol is a key player in blood sugar metabolism and insulin sensitivity.

High cortisol levels are also associated with increased fat deposits around the abdomen, or belly fat, which is a risk factor for type 2 diabetes.

In short, the theory suggests, the more depressed someone is, the more cortisol they produce, which leads to more belly fat and more diabetes, says Wagner.

Depression may also influence type 2 diabetes risk by disrupting the immune system or levels of serotonin, which helps modulate metabolic function as well as mood, Wagner says.

Depression and diabetes researcher Patrick Lustman, PhD, tells WebMD that understanding how depression influences diabetes could have major implications for the management of at-risk patients.

Lustman is a professor of psychiatry at Washington University School of Medicine in St. Louis.

"When you think of interventions that target both depression and diabetes, physical activity has to be at the top of the list," he tells WebMD. "Exercise is the most powerful preventive medicine we have for type 2 diabetes, and it is arguably among the most powerful treatment for depression."

Show Sources


American Diabetes Association 69th Scientific Sessions, New Orleans, June 5-9, 2009.

Julie Wagner, PhD, associate professor, division of behavioral sciences and community health, University of Connecticut Health Center, New Haven, Conn.

Patrick Lustman, PhD, professor of psychiatry, Washington University School of Medicine, St. Louis.

Mezuk, B. Diabetes Care, December 2008; vol 31: pp 2383-2390.

© 2009 WebMD, LLC. All rights reserved. View privacy policy and trust info